2011
DOI: 10.1016/j.bmc.2011.08.062
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, biophysical and biological studies of trisubstituted naphthalimides as G-quadruplex ligands

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 35 publications
(14 citation statements)
references
References 49 publications
0
14
0
Order By: Relevance
“…Some trisubstituted derivatives with the same naphthalimido aromatic nucleus of compound 2 have already been evaluated as telomeric G4 binders and telomerase inhibitors 34. Notably, compounds of this series are characterized by three substituents and side chains different from that of compound 2 (SI, Figure S5).…”
Section: Discussionmentioning
confidence: 99%
“…Some trisubstituted derivatives with the same naphthalimido aromatic nucleus of compound 2 have already been evaluated as telomeric G4 binders and telomerase inhibitors 34. Notably, compounds of this series are characterized by three substituents and side chains different from that of compound 2 (SI, Figure S5).…”
Section: Discussionmentioning
confidence: 99%
“…Compounds I and II were prepared starting from commercially available 1,3-dimethoxybenzene (2a) and 1-hexyl-2,4-dimethoxybenzene (2b) that were easily prepared according to procedure described by Kikuchi and co-workers [12-14]. Condensation of cyclohexanone with 2a-b gave the tertiary alcohols 3a-b in 70% and 80% yields respectively.…”
Section: Methodsmentioning
confidence: 99%
“…As a part of our research program devoted to the preparation and evaluation of new antiproliferative agents, [12-14] the para-quinone of cannabinol HU-331 (1) was selected as biologically validated starting point for compound library development, in order to evaluate the structural requirements important for biological activity and in particular the role of the substituents linked to the quinone nucleus.…”
Section: Introductionmentioning
confidence: 99%
“…To confirm the implication of 5-LO in the pathogenesis of cancer, researchers have used several medications such as 5-LO inhibitors (zileuton, ZYflo, ABT-761), FLAP inhibitors (MK-886) or other related drugs (zafirlukast and montelukast) in inhibiting cell proliferation and inducing cell death in vitro and in vivo [11]. Our group has synthesized and characterized several agents such as quinone-based derivatives with anti-cancer and anti-inflammatory properties [12,13,14,15,16,17,18,19,20,21,22,23]. These studies on the development of quinone-based compounds with antitumor activity have led to investigate the natural compound embelin and its analogues known as inhibitors of 5-LO and able to suppress proliferation of GBM cells [24].…”
Section: Introductionmentioning
confidence: 99%